Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LENZ Therapeutics, Inc. (LENZ) Cash from Financing Activities (2022 - 2023)

LENZ Therapeutics (LENZ) has disclosed Cash from Financing Activities for 2 consecutive years, with -$1.9 million as the latest value for Q4 2023.

  • On a quarterly basis, Cash from Financing Activities fell 883.2% to -$1.9 million in Q4 2023 year-over-year; TTM through Dec 2023 was $80.7 million, a 13417.59% increase, with the full-year FY2024 number at $199.0 million, up 146.59% from a year prior.
  • Cash from Financing Activities was -$1.9 million for Q4 2023 at LENZ Therapeutics, down from -$568000.0 in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $83.2 million in Q1 2023 to a low of -$1.9 million in Q4 2023.